Beyond the Prescription: Optimizing Obesity Care with Personalized Nutrition and Lifestyle Support
While GLP-1 medications are generating excitement for obesity treatment, their rising costs pose a challenge. Amidst this dynamic, one truth remains constant: lifestyle-first strategies are foundational to effective obesity management. Prioritizing these offers a powerful trifecta: significant cost savings, improved health outcomes, and high member satisfaction. Understanding the Evolving Landscape of Obesity Treatment GLP-1s are
Testimonial: Jeffrey’s Story
Success stories from Welldoc’s digital health app As an individual living with Becker’s muscular dystrophy, a progressive genetic condition, Jeffrey Harris is experienced at navigating chronic health challenges. The 76-year-old from the Washington, D.C. later had health scare that also revealed dangerously high A1C levels. For him, this meant a new diagnosis to manage: diabetes.
4 Strategies for PBMs: Managing GLP-1 Costs with Digital Health
The rising cost of weight loss drugs, reaching as high as $1,350 per month*, coupled with increasing employee demand, presents a considerable financial challenge for employers. However, the costs associated with glucagon-like peptide-1 (GLP-1) agonists don’t have to spiral out of control. Pharmacy Benefit Managers (PBMs) are critical in curbing the escalating expenses linked to
